Extract from the Register for Unitary Patent Protection

UP About this file: EP3717916  C0

EP3717916 - TARGET INTERFERENCE SUPPRESSED ANTI-DRUG ANTIBODY ASSAY [Right-click to bookmark this link]
StatusUnitary effect registered
Database last updated on 28.03.2026
FormerRequest for unitary effect filed
Status updated on  22.01.2025
Most recent event   Tooltip24.10.2025New entry: Payment of renewal fee 
Proprietor(s)For all participating member states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2025/09]  
Inventor(s)01 / DAHL, Uwe
c/o Roche Diagnostics GmbH
Nonnenwald 2
82377 Penzberg / DE
02 / JORDAN, Gregor
c/o Roche Diagnostics GmbH
Nonnenwald 2
82377 Penzberg / DE
03 / STAACK, Roland
c/o Roche Diagnostics GmbH
Nonnenwald 2
82377 Penzberg / DE
04 / MOHEYSEN-ZADEH, Miriam
c/o Roche Diagnostics GmbH
Nonnenwald 2
82377 Penzberg / DE
 [2020/41]
Representative(s)Skolaut, Alexander
Roche Diagnostics GmbH
Patentabteilung
LPAA....6164
Nonnenwald 2
82377 Penzberg / DE
[2025/09]
Application number, filing date18804654.427.11.2018
[2020/41]
WO2018EP82664
Procedural languageEN
(Principal) place of business   Tooltip
on the date of filing
 Principal place of businessTooltip
Unitary Patent Protection22.01.2025Date of request for unitary effect [2025/09]
28.01.2025Decision on the request for unitary effect:  Positive [2025/09]
28.01.2025Date of registration  [2025/09]
01.01.2025Date of legal effect  [2025/09]
Member States covered by Unitary  Tooltip
Patent Protection
28.01.2025AT, BE, BG, DE, DK, EE, FI, FR, IT, LT, LU, LV, MT, NL, PT, RO, SE, SI  [2025/09]
PublicationType: B1 Patent specification 
No.:EP3717916
Date:01.01.2025
Language:EN
[2025/01]
Renewal fees paidRenewal fee
22.10.2025Renewal fee unitary effect year  08
The European Patent Register provides the information on unitary patent protection required under R. 16(1) UPR. "Status" and "Most recent event" are not entries required under R. 16(1) UPR and should therefore be regarded as additional information only.

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes. Please refer to the relevant national patent authority for SPC data.